The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.

The Federal Trade Commission has accused three major pharmacy benefit managers of inflating insulin prices, the agency said ...

This was the stock's second consecutive day of losses.

The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing ...

UnitedHealth Group division calls the action “baseless” and shows “profound misunderstanding” of drug pricing.

The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes ...

The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing ...

On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices.

Change Healthcare says the breach may have exposed health information, payment information, and personal details like social ...